Related references
Note: Only part of the references are listed.Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
Magdy El-Salhy et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2021)
Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
Lynne McFarland et al.
ECLINICALMEDICINE (2021)
Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut models
Charlene Roussel et al.
GUT MICROBES (2021)
Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study
Eric D. Shah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome
Ravichandran Gayathri et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Global burden of irritable bowel syndrome: trends, predictions and risk factors
Christopher J. Black et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders
Geoffrey A. Preidis et al.
GASTROENTEROLOGY (2020)
Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome
Ruben A. T. Mars et al.
CELL (2020)
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis
Caterina Carco et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
Jan Tack et al.
BMC GASTROENTEROLOGY (2019)
Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey
Sarah Ballou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
Yu Gu et al.
FRONTIERS IN MICROBIOLOGY (2019)
Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats
Jindong Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus
A. P. S. Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Anti-infectious properties of the probiotic Saccharomyces cerevisiae CNCM I-3856 on enterotoxigenic E. coli (ETEC) strain H10407
C. Roussel et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation
Sarah Ballou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem
Asa Frandemark et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
Alexander C. Ford et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries
Imran Aziz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS
S. Ballou et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis
Amelie Cayzeele-Decherf et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Pharmacotherapy for Irritable Bowel Syndrome
Michael Camilleri et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Irritable bowel syndrome: a gut microbiota-related disorder?
Yogesh Bhattarai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
Robin Spiller et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2016)
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Douglas A. Drossman
GASTROENTEROLOGY (2016)
A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome
Guillaume Pineton de Chambrun et al.
DIGESTIVE AND LIVER DISEASE (2015)
Saccharomyces cerevisiae CNCM I-3856 Prevents Colitis Induced by AIEC Bacteria in the Transgenic Mouse Model Mimicking Crohn's Disease
Adeline Sivignon et al.
INFLAMMATORY BOWEL DISEASES (2015)
Review article: the economic impact of the irritable bowel syndrome
C. Canavan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome
Lin Chang et al.
GASTROENTEROLOGY (2014)
Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life
Lena Bohn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome
T. Banasiewicz et al.
COLORECTAL DISEASE (2013)
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Magnus Simren et al.
GUT (2013)
Modulation of Intestinal Inflammation by Yeasts and Cell Wall Extracts: Strain Dependence and Unexpected Anti-Inflammatory Role of Glucan Fractions
Samir Jawhara et al.
PLOS ONE (2012)
Saccharomyces cerevisiae Modulates Immune Gene Expressions and Inhibits ETEC-Mediated ERK1/2 and p38 Signaling Pathways in Intestinal Epithelial Cells
Galliano Zanello et al.
PLOS ONE (2011)
Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome
A. C. Ford et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Probiotic yeasts: Anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice
Benoit Foligne et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment
Douglas Drossman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Health-related quality of life in patients attending a gastroenterology outpatient clinic:: Functional disorders versus organic diseases
M Simrén et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Abdominal pain impacts quality of life in women with irritable bowel syndrome
KC Cain et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study
SLS Halder et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Health-related quality of life among persons with irritable bowel syndrome: a systematic review
HB El-Serag et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Food-related gastrointestinal symptoms in the irritable bowel syndrome
M Simren et al.
DIGESTION (2001)
Share Paper
